HeartStart MRx Processor Board PCA Replacement Kits 453563478461, a component of the Philips Hea...

FDA Device Recall #Z-2064-2020 — Class II — April 10, 2020

Recall Summary

Recall Number Z-2064-2020
Classification Class II — Moderate risk
Date Initiated April 10, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Philips North America, LLC
Location Andover, MA
Product Type Devices
Quantity 8 units (2 US and 6 OUS)

Product Description

HeartStart MRx Processor Board PCA Replacement Kits 453563478461, a component of the Philips HeartStart MRx Monitorl/Defibrillator - Product Usage: is intended for use in hospital and prehospital settings by qualified medical personnel trained in the operation of the device and qualified by training in basic life support, advanced cardiac life support or defibrillation.

Reason for Recall

Damaged ESD bags used for storing components in Processor PCA Replacement Kits

Distribution Pattern

Worldwide distribution - US Nationwide distribution including in the states of OK, NY and the countries of Libya, Netherlands, Canada, South Africa, United Kingdom.

Lot / Code Information

Serial Numbers: CO1-1643IDOTDB CO1-1639100N3T C01-16391D0NB2, CO1-1639100N43 C01-1639100ND0 C01-16391D0N6N, C01-16391D0N4N C01-1&39IDON1J

Other Recalls from Philips North America, LLC

Recall # Classification Product Date
Z-0926-2022 Class II The IFU for the Autoclavable Temperature Probes... Feb 7, 2022
Z-1326-2021 Class II Philips SureSigns VM4, VM6 and VM8 - Product Us... Mar 23, 2021
Z-0852-2021 Class II Emission Computed Tomography System Image Proce... Nov 19, 2020
Z-0284-2021 Class II Philips Sterilizable Defibrillator Paddles, Swi... Sep 14, 2020
Z-0285-2021 Class II Philips Sterilizable Defibrillator Paddles, Swi... Sep 14, 2020

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.